Dr. Currier is trained both in Infectious Diseases and Clinical Epidemiology, and her research interests include the treatment and prevention of complications of antiretroviral therapy, gender-related issues in HIV therapy and the evaluation of antiretroviral treatment strategies in resource limited settings. Dr. Currier has been involved in the conduct of clinical research studies focused on improving the treatment of HIV infection. Her work has been conducted through the NIAID funded AIDS Clinical Trials and through industry funded studies. Dr. Currier is the Principal Investigator for the UCLA AIDS Prevention and Treatment Clinical Trials Unit and Vice Chair of the AIDS Clinical Trials Group (ACTG). Her areas of research focus include understanding the pathogenesis and management of long term complications of HIV disease, specifically cardiovascular and metabolic complications associated with HIV treatment.